Mark Andrew Graham

1 Patent

• US123656782025

  Pharmaceutical Process for the Preparation of 4-{4-[(3r)-3-methylmorpholin-4-yl]-6-[1-((r)-s-methylsulfonimidoyl) Cyclopropyl]pyrimidin-2-yl}-1h-pyrrolo[2,3-b] Pyridine and Intermediates

  0 cites